More than 5.2 million Americans have Alzheimer’s disease. Another 7.7 million Americans will suffer with it by 2030, and another 16 million will suffer by 2050. And there’s a yearly price tag of $148 billion to treat these patients.
No one is quite sure what causes the disease that gradually robs sufferers of memory [...]
Monday, June 16, 2008
Anavex: Outlook For This Drug Company
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment